Pandion Therapeutics
Pandion Therapeutics

Pandion Therapeutics Information

Contact top employees from Pandion Therapeutics

Summary

Pandion Therapeutics is a public company that has been in the industry for 9 years. The company currently specializes in the Biotechnology, Pharmaceuticals, Biotechnology areas. The position of the CEO is occupied by Rahul Kakkar. Its headquarters is located at Watertown, Massachusetts, USA. The number of employees ranges from 25 to 100. The annual revenue of Pandion Therapeutics varies between 5.0M and 25M. Total funding of the company - $273M. To connect with Pandion Therapeutics employee register on SignalHire.

Organization Website

pandiontx.com

Social Links

linkedIntwitter

Phone Number

617-393-5925

Industries

Headquarters Location

700 North Main Street, Cambridge, Massachusetts, 02139 US

Employees Size

1-10 employees

SIC Code

2834, 2836

DMA Code

Greater Boston

Founded

2016

Estimated Annual Revenue

$5.0M - 25M

Operating Status

Subsidiary

Competitors

Founded
Type
Employees
Revenue
Funding
2007Public
Company
250 - 500 221.9M $142.1M
2018Privately
Held
25 - 100 2.5M $113.8M
2011Privately
Held
25 - 100 4M $12.5M
1988Public
Company
5.0K - 10K 12.4B $2.1B

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Pandion Therapeutics shows a diverse range of experience levels:
11% for 3–4 years67% for 5–7 years22% for 8–10 years
Contact top employees from Pandion Therapeutics
Bilian Li MS
Senior Scientist
View
Jessica Beltrán
Manager, Lab & Facilities Services
View
Dan Matloff
Chief Financial Officer (Consulting)
View
Jo Viney
Co-Founder and CSO
View
Kevin Otipoby
Director of Immunology
View

FAQ

Pandion Therapeutics operates in the Biotech industries. More details can be found on the official website: pandiontx.com.
The headquarters of Pandion Therapeutics are located in Cambridge, United States.
The current CEO of Pandion Therapeutics is Rahul Kakkar
You can contact Pandion Therapeutics by phone at 617-393-5925.
Pandion Therapeutics currently employs 1-10 people.
Pandion Therapeutics's revenue is approximately 8.8M.
Well-known competitors of Pandion Therapeutics include Akebia Therapeutics, Cedilla Therapeutics, Acesion Pharma and Regeneron.
BACK TO TOP